Home

Results 51 - 60 of 12,948 for injected. Search took 4.544 seconds.  
Sort by date/Sort by relevance
WHO recommendation on umbilical vein injection of oxytocin for the treatment of retained placenta Global Regions WHO Regional websites Africa Americas South-East Asia Europe Eastern Mediterranean Western Pacific When autocomplete results are available use up and down arrows to review and enter to select. Select language Select language English العربية 中文 Français Русский Español Português Home Health Topics All topics » A B C D E F G H I J K L M N O P Q R S T U V W X Y Z Resources » Fact sheets Facts in pictures Multimedia Publications Questions & answers Tools and toolkits Popular » Coronavirus disease (COVID-19) Ebola virus disease Air pollution Hepatitis Top 10 causes of death World Health Assembly » Countries All countries » A B C D E F G H I J K L M N O P Q R S T U V W X Y Z Regions » Africa Americas South-East Asia Europe Eastern Mediterranean Western Pacific WHO in countries » Statistics Cooperation strategies Yemen crisis » Sadeq Al Wesabi Hasan An internally displaced family in a camp in Hudaydah © Credits   Newsroom All news » News releases Statements Campaigns Commentaries Events Feature stories Speeches Spotlights Newsletters Photo library Media distribution list Headlines » Timeline: WHO's COVID-19 response »   Emergencies Focus on » COVID-19 pandemic Ebola virus disease outbreak DRC 2021 Syria crisis Crisis in Northern Ethiopia Afghanistan Crisis Latest » Disease Outbreak News Travel advice Situation reports Weekly Epidemiological Record WHO in emergencies » Surveillance Research Funding Partners Operations Independent Oversight and Advisory Committee Health Emergency Dashboard » WHO © Credits Data Data at WHO » Global Health Estimates Health SDGs Mortality Triple billion targets Data collections Dashboards » COVID-19 Dashboard Triple Billion Dashboard Health Equity monitor Mortality Highlights » GHO SCORE Insights and visualizations Data collection tools Reports World Health Statistics 2021 » WHO © Credits About WHO About WHO » People Teams Structure Partnerships Collaborating Centres Networks, committees and advisory groups Transformation Our Work » General Programme of Work WHO Academy Activities Initiatives Funding » Assessed contributions Flexible funding WHO Foundation Accountability » Audit Budget Financial statements Programme Budget Portal Results Report Governance » World Health Assembly Executive Board Election of Director-General Governing Bodies website Home / Publications / i / item / WHO recommendation on umbilical vein injection of oxytocin for the treatment of retained placenta - Select language - العربية 中文 français русский español português WHO recommendation on umbilical vein injection of oxytocin for the treatment of retained placenta 4 November 2020  |  Guideline Download (686.5 kB) Overview In 2019, the Executive Guideline Steering Group (GSG) for the World Health Organization (WHO) maternal and perinatal health recommendations prioritized updating of the existing WHO recommendation: Umbilical vein injection of oxytocin for the treatment of retained placenta, in response to the availability of new evidence. The recommendation in this document thus supersedes the previous WHO recommendations on “intraumbilical vein injection of oxytocin for treatment of retained placenta” as published in the 2012 guideline, WHO recommendations for the prevention and treatment of postpartum haemorrhage .
Language:English
Score: 915842.5 - https://www.who.int/publications/i/item/9789240013940
Data Source: un
Seroprevalence among highly affected populations of injecting drug users has reached as high as 48% in Jakarta, 53% in Denpasar, Bali, and 24% in West Java. (...) The 2002 national estimates indicated that the HIV prevalence ranges from 19% to 34% among injecting drug users and from 2% to 5% among sex workers. (...) HIV transmission in Indonesia was initially related to sexual transmission, but transmission among injecting drug users has increased eight-fold since 1998.
Language:English
Score: 914539.2 - https://www.who.int/3by5/support/june2005_idn.pdf
Data Source: un
Search results Polio Report 10/13/2018 Injectable Polio Vaccine (IPV): Flyer What parents and caregivers need to know Download file (PDF, 860,17 KB) Report 10/13/2018 Injectable Polio Vaccine (IPV): Fact sheet What you need to know Download file (PDF, 276,22 KB) Report 08/14/2018 Injectable Polio Vaccine (IPV): Booklet What parents and caregivers need to know Download file (PDF, 1,07 MB) Video 05/15/2018 My children rarely fall sick because of immunization For every child, a vaccine Footer UNICEF Home What we do Research and reports Stories Take action About us Press centre UNICEF in Uganda Our representative Work with us Procurement Become a donor Social Footer Secondary Contact Legal Footer tertiary Report fraud, abuse, wrongdoing
Language:English
Score: 914374.2 - https://www.unicef.org/uganda/topics/polio
Data Source: un
This week, WHO has also added a new generic treatment to its list of WHO-prequalified hepatitis C medicines to increase access to therapy, and is promoting prevention through injection safety: a key factor in reducing hepatitis B and C transmission. (...) There is also an urgent need to scale up access to hepatitis B testing. Improving injection safety and infection prevention to reduce new cases of hepatitis B and C Use of contaminated injection equipment in health-care settings accounts for a large number of new HCV and HBV infections worldwide, making injection safety an important strategy.Others include preventing transmission through invasive procedures, such as surgery and dental care; increasing hepatitis B vaccination rates and scaling up harm reduction programmes for people who inject drugs. Today WHO is launching a range of new educational and communication tools to support a campaign entitled "Get the Point-Make smart injection choices" to improve injection safety in order to prevent hepatitis and other bloodborne infections in health-care settings.  
Language:English
Score: 913272.9 - https://www.who.int/news/item/...7-2017-eliminate-hepatitis-who
Data Source: un
One of them is a 21-year-old boy, a heroin injecting drug user. The woman sitting beside him is his mother. (...) At the age of 17 I tried heroin and I'd been injecting it for four years." He became a regular drug user at the age of 12. (...) A month ago he decided to quit injecting heroin. The latest HIV/Hepatitis B and C tests show that he is clean.
Language:English
Score: 913272.9 - https://www.unicef.org/serbia/en/stories/bliss-dark
Data Source: un
The revised recommendation is that progestogen-only injectables (norethisterone enanthate [NET-EN] and depot medroxyprogesterone acetate [DMPA, intramuscular or subcutaneous]) can be used by women at high risk of HIV, because the advantages of these methods generally outweigh the possible, but unproven, increased risk of HIV acquisition. (...) This is now changed to a category 2; meaning women can use progestogen-only injectables but should be advised about concerns that these methods may increase risk of HIV acquisition, about the uncertainty over whether there is a causal relationship, and about how to minimize their risk of acquiring HIV. This revised guidance places greater emphasis on the importance of shared decision making and need for counselling on concerns that progestogen-only injectables may increase the risk of HIV infection.
Language:English
Score: 911506 - https://www.who.int/reproducti...hormonal-contraception-hiv/en/
Data Source: un
TDR Image Library Tel: (+41) 22 - 791 - 3764 Fax: (+41) 22 - 791 - 4854 E-mail: tdr@who.int Web: www.who.int/tdr UNDP/World Bank/WHO Special Programme for Research & Training in Tropical Diseases (TDR) Leishmaniasis Videobite tape : Shot list Time Code SCENE 02 00 00 Sudan: Male doctor in ward examining young boy with visceral leishmaniasis 02 17 13 Man with visceral leishmaniasis (c/u) 02 21 21 Ward with visceral leishmaniasis patients (Sudan) 02 29 18 Doctor examining 8 year old boy with swollen abdomen (Sudan) 02 48 13 Doctor examines 4 year old girl with grandmother /crying (Sudan) 02 57 10 Doctor examining young man in bed (Sudan) 03 02 09 Doctor examines badly infected boy (Sudan) 03 12 10 Young Muslim girl with cutaneous leishmaniasis lesions on arm (+ cream on lesion) 03 24 09 Cutaneous leishmaniasis lesions on wrists of boy (Sudan) 03 35 19 Cutaneous leishmaniasis lesions on leg of woman (Sudan) 03 45 11 Cutaneous leishmaniasis lesions on foot of boy (Iran) 03 49 02 Cutaneous leishmaniasis lesions on throat of boy (Iran) 03 55 01 Cutaneous leishmaniasis on face of young child (Uzbekistan) 04 04 24 Cutaneous leishmaniasis on nose of young girl (Iran) 04 13 03 Environmental conditions in which leishmaniasis is commonly found (Sudan) 04 36 20 Environmental conditions, boy picking cotton (Uzbekistan) 04 52 05 Gerbils - reservoir hosts(Uzbekistan) 05 14 20 Adult sandflies 05 24 14 Photomicrograph of Leishmania parasites in macrophages (24 hours after activation) 05 34 14 Photomicrograph of Leishmania parasites in macrophages (48 hours after activation) 05 44 14 Photomicrograph of Leishmania amazonensis parasites 05 54 14 Photomicrograph of Leishmania parasites in macrophages 06 04 14 Splenic puncture (India) 06 15 08 Making slide with spleen tissue (India) 06 24 15 Patient receiving an injection of pentostam (Sudan) 06 51 14 Young girl getting finger prick/ blood blot on paper (Sudan) 07 09 03 Making slide of blood sample (Sudan) 07 18 18 c/u of blood being smeared on slide (Sudan) 07 31 10 Taking a probe from child (aspirate) in groin area (Sudan) 07 47 22 Putting same sample on a glass slide (Sudan) 07 53 08 Woman with lesion on hand is treated by doctor (Iran) 07 59 07 Doctor treats lesion on leg (Iran) 08 10 16 Preparing glass slide 08 15 11 Doctor treating patient with drip on ward (India) 08 40 00 Placing media bottles with L.major in incubator and setting temperature (Razi Institute, Iran) December 2000 TDR Image Library Tel: (+41) 22 - 791 - 3764 Fax: (+41) 22 - 791 - 4854 E-mail: tdr@who.int Web: www.who.int/tdr UNDP/World Bank/WHO Special Programme for Research & Training in Tropical Diseases (TDR) Time Code SCENE 09 04 01 Laboratory, looking at bottle of medium/cell culture under microscope (Iran) 09 20 15 Removing Leishmania seed from liquid nitrogen (Iran) 09 27 17 Labelling bottles of vaccine 09 30 24 Labelling bottles of vaccine with 'WHO /TDR' labels 09 40 10 Taking labelled bottles and walks to different room 09 57 11 c/u takes vaccine bottle from cooler 10 04 10 Fills syringe with vaccine 10 06 23 Young boy receives injection (Iran) 10 20 18 Different boy gets injection (Iran) 10 35 23 c/u of injection (Sudan) 10 47 19 Young girl gets injection (Iran) 11 02 00 Measuring lesion on arm (Iran) 11 11 12 Measuring lesion on arm (Sudan) 11 20 11 Female checking records (Iran) 11 42 15 Boy has lesion on hand treated with paromomysin ointment (Iran) 11 57 06 c/u foot being treated with paromomysin ointment 12 06 12 Three boys with paromomysin ointment on sores (Iran) 12 16 06 Healed lesion on man's arm 12 24 10 Young children sleeping under bednet (Iran) 13 15 09 Lab scenes (Sudan) Leishmaniasis (continued) Videobite tape : Shot list
Language:English
Score: 911506 - https://www.who.int/tdr/public...s/videos/video-bites/leish.pdf
Data Source: un
The report, Do no harm: health, human rights and people who use drugs , which was issued by the Joint UN Programme on HIV/AIDS ( UNAIDS ), shows that between 2010 and 2014, the failure of many countries to adopt people-centred approaches resulted in no reduction in the global number of new HIV infections among people who inject drugs. And the world missed the General Assembly’s target set in 2011 to reduce HIV transmission among people who inject drugs by 50 per cent by 2015. (...) “The world must learn the lessons of the past 15 years, following the example of countries that have reversed their HIV epidemics among people who inject drugs by adopting harm reduction approaches that prioritize people’s health and human rights.” (...) Data demonstrate that countries implementing health- and rights-based approaches have reduced new HIV infections among people who inject drugs. In other countries, strategies based on criminalization and aggressive law enforcement have created barriers to harm reduction while having little or no impact on the number of people who use drugs.
Language:English
Score: 909894.8 - https://news.un.org/en/story/2...iv-infections-among-drug-users
Data Source: un
Injection Projects Working Group | UNECE Skip to main content English Advanced Search   Main navigation About UNECE Executive Secretary Mission Organizational structure Secretariat Executive Committee Commission Legal instruments Work with us Our work Economic Cooperation & Integration Environmental Policy Forests Housing & Land Population Sustainable Energy Statistics Trade Transport Themes High-impact Areas Circular Economy Gender SPECA Technical cooperation THE PEP UN SG's Special Envoy for Road Safety UN Road Safety Fund UN cooperation in the UNECE region Regional Forum on Sustainable Development SDGs Open UNECE Events Meetings & Events Information for Delegates Coronavirus Advisory Publications Media Executive Secretary's Blog News Press Releases Covid-19 Press Releases Speeches Stories UNECE Weekly Videos UNECE Injection Projects Working Group More options Injection Projects Working Group Chair Ms.
Language:English
Score: 907192.5 - https://unece.org/injection-projects-working-group-0
Data Source: un
The purpose of this specialized training was to orient, advocate and train governmental public health decision-makers, and NGO programme managers on the comprehensive package of HIV prevention and care services to people who inject drugs including community outreach programmes to hard to reach drug users. The Workshop served to further UNODC technical support to maintain a low HIV epidemic among people who inject drugs in the occupied Palestinian Territory with funding from the Global Fund to Fight AIDS, TB and Malaria (GFATM).   (...) Al Maqdese had reached 255 drug users (of which 175 inject drugs) in the West Bank, including in East Jerusalem, with 1,500 sterile needles and syringes and 1,100 male condoms during a five-month period in 2010.
Language:English
Score: 902955 - https://www.un.org/unispal/document/auto-insert-208485/
Data Source: un